New AIDS Vaccine Trial a Success in India
When it came to writing the August 25 cover story, "The Quest for an AIDS Vaccine," I found so much information on the potential vaccine that I didn't know what to do with it all. I also discovered many institutions around the world are at different points with creating a vaccine.
Recently, the International AIDS Vaccine Initiative (IAVI) released a press release citing India's efforts in AIDS vaccine development. According to the release, "The results of the trial of an MVA-based AIDS vaccine candidate (TBC-M4), which was conducted in Chennai, indicated that the vaccine candidate had acceptable levels of safety and was well tolerated."
It is important that AIDS vaccine trials are also conducted in other areas around the world, considering 2.7 million people are infected annually around the globe, according to the IAVI.